ArticleNucleic acids research2026
Mechanism of the long-B prokaryotic Argonaute-mediated nuclease activation in bacterial immunity.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Prokaryotic Argonautes (pAgos) are widely distributed and provide immunity against invading DNA. Based on their domain architecture, pAgos are classified into three major groups: long-A, long-B, and short pAgos. Among them, long-B pAgos remain the least understood subgroup. Here, we show that a long-B pAgo-nuclease system (EcBPAN) from Escherichia coli (E. coli) provides the first clear evidence of anti-phage activity among long-B pAgo systems. By combining structural determination, biochemical analyses, and in vivo phage-resistance assays, we elucidated the activation mechanism of EcBPAN. We found that RNA-guided EcAgo recognizes target DNA and subsequently recruits the autoinhibited EcbAgaN (long-B pAgo-associated nuclease from E. coli) dimer to form an unprecedented 8:8 pAgo-nuclease complex with robust nonspecific DNase activity. The cryo-EM structure of the activated complex revealed a distinctive bowl-shaped architecture, in which the C-terminal nuclease domains of EcbAgaN form an active octamer, while the N-terminal domains engage four EcAgo-guide RNA-target DNA ternary dimers in an interleaved manner, thereby relieving autoinhibition. Together, these findings provide mechanistic insights into the long-B pAgo defense system and reveal a mode of immune activation that is distinct from those of long-A and short pAgo systems, its supramolecular assembly and regulatory mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.